Analyst Ratings February 11, 2026

Cantor Fitzgerald Cuts Klaviyo Target to $35 but Keeps Overweight Rating

Firm cites lower software multiples even as Klaviyo posts strong Q4 growth, improved margins and rising multi-product ARR

By Priya Menon KVYO
Cantor Fitzgerald Cuts Klaviyo Target to $35 but Keeps Overweight Rating
KVYO

Cantor Fitzgerald trimmed its price objective for Klaviyo Inc. (NYSE:KVYO) to $35 from its prior target while retaining an Overweight rating. The new target implies roughly 65% upside from the most recent share price of $21.20. The move follows a quarter of stronger-than-expected top-line growth, improved free cash flow margins and rising revenue from multi-product customers, even as sector-wide valuation compression prompted multiple analyst firms to lower their targets.

Key Points

  • Cantor Fitzgerald cut its Klaviyo price target to $35 but kept an Overweight rating; the target implies roughly 65% upside from a $21.20 share price.
  • Klaviyo reported stronger-than-expected Q4 results with nearly 30% year-over-year revenue growth, Net Revenue Retention at 110%, and over 37% growth among customers spending $50,000 or more; trailing 12-month revenue growth is 32.8% (InvestingPro).
  • Several brokerages trimmed price targets citing compressed software multiples despite acknowledging strong operational performance; analyst targets now range from $29 to $51.

Cantor Fitzgerald has lowered its price target on Klaviyo Inc. (NYSE:KVYO) to $35.00, while keeping an Overweight rating on the marketing automation company. At the stated $21.20 share price, the $35 target reflects about a 65% upside. Analyst targets cited span a range from $29 to $51, and InvestingPro data flags the stock as appearing undervalued on Fair Value metrics.

The brokerage's reassessment arrives despite Klaviyo delivering a stronger-than-expected fourth quarter. Revenue grew nearly 30% year-over-year versus company guidance that had been roughly 23%. Management also reported a rise in Net Revenue Retention to 110% and more than 37% growth in the cohort of customers spending $50,000 or more annually. InvestingPro data show Klaviyo's trailing 12-month revenue growth at 32.8%, underscoring the company’s recent growth trajectory.

On the margin and cash-flow side, Klaviyo posted roughly a 500 basis point improvement in free cash flow margin for the quarter. Cantor Fitzgerald attributed the improvement in part to continued organic usage expansion across the platform and pointed to the company’s non-seat-based pricing model as a contributor to the better-than-expected profile. The firm also highlighted that meaningful cross-selling of new functionality has driven Annual Recurring Revenue from multi-product customers to account for more than 60% of total revenue, with scaling efficiencies further aiding profitability.

Despite these operational positives, Cantor Fitzgerald trimmed its price target to reflect what it described as "lower multiples across the software universe." The firm nonetheless reiterated that Klaviyo "is positioned to capture significant market share and effectively monetize AI going forward" and that shares "should remain a key holding for long-term investors."

Other sell-side shops have similarly revisited their targets in light of the current valuation backdrop even as they acknowledged Klaviyo's recent performance. Piper Sandler reported that Klaviyo beat top-line expectations by 5.2% in the quarter and exceeded operating income projections by 14.6%. Management also guided fiscal year 2026 revenue to a midpoint of 22% growth, slightly higher than its preliminary guidance.

Several firms adjusted their targets following the quarter. Truist Securities lowered its price target to $35, citing sector valuation compression while maintaining a Buy rating. Needham trimmed its target to $30, noting robust holiday-season sales and customer expansion. KeyBanc reduced its target to $40 based on prevailing market multiples while recognizing Klaviyo’s strong 2025 performance. TD Cowen cut its target to $35 after the company reported roughly 30% growth, above the firm’s prior estimate of 24%.

The market reaction to Klaviyo's results and the subsequent round of target changes illustrates the tension between company-level operational progress and a broader software valuation reset. Klaviyo's reported lift in revenue growth, improved free cash flow margin and rising contribution from multi-product customers point to strengthening unit economics and platform leverage. At the same time, analysts are adjusting valuations to reflect compressed multiples across the sector, producing a spread of price targets from $29 to $51.


Key metrics and analyst notes:

  • New Cantor Fitzgerald target: $35.00; rating: Overweight.
  • Share price referenced: $21.20; implied upside: ~65%.
  • Analyst target range cited: $29 to $51.
  • Trailing 12-month revenue growth (InvestingPro): 32.8%.
  • Quarterly revenue growth: nearly 30% year-over-year (company guidance ~23%).
  • Net Revenue Retention: 110%.
  • Customers spending $50,000+: >37% growth.
  • Free cash flow margin: ~500 basis points improvement quarter-over-quarter.
  • ARR from multi-product customers: >60% of revenue.

The data present a picture of a company improving both top-line growth and cash generation while increasing its mix of higher-value, multi-product customers. Yet the downward reset to price targets across several brokerages signals that market-wide multiples remain a decisive factor in near-term valuation.

Risks

  • Sector valuation compression - multiple firms lowered targets, and Cantor Fitzgerald cited "lower multiples across the software universe," indicating that market-wide valuation trends can weigh on stock price and target levels.
  • Analyst target dispersion - a range of $29 to $51 across analysts reflects uncertainty in consensus valuation and highlights sensitivity to differing assumptions about growth and multiples.
  • Market multiples and investor sentiment - even with improved revenue growth and cash flow margins, adjustments to market multiples have prompted price-target reductions, creating valuation risk for investors in the software and marketing-technology sectors.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026